FOREFRONT ANALYTICS, LLC – Eiger BioPharmaceuticals, Inc. Transaction History
FOREFRONT ANALYTICS, LLC portfolio value:
$0
portfolio value
FOREFRONT ANALYTICS, LLC quarter portfolio value change:
+19.52%
quarter
Eiger BioPharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -11.52K shares | -73K | $7.53 | 0 |
| Q2 2022 | share | Increase | +6.47% | 700 shares | -14K | $6.3 | 11.52K |
| Q1 2022 | share | Increase | +4.59% | 475 shares | 29K | $8.3 | 10.82K |
| Q4 2021 | share | Increase | +2.73% | 275 shares | -10K | $5.21 | 10.35K |
| Q3 2021 | share | Increase | +0.50% | 50 shares | -14K | $6.68 | 10.07K |
| Q2 2021 | share | Decrease | -6.84% | -736 shares | -15K | $8.52 | 10.02K |
| Q1 2021 | share | Increase | 0.00% | 10.76K shares | 97K | $8.85 | 10.76K |